Abstract
Summary
Chronic obstructive pulmonary disease (COPD) and asthma devices are useful in inhalation therapy and assist in drug delivery by converting drug suspensions or solutions to aerosolized particles.
LPI (LP Information)' newest research report, the “COPD and Asthma Devices Industry Forecast” looks at past sales and reviews total world COPD and Asthma Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected COPD and Asthma Devices sales for 2023 through 2029. With COPD and Asthma Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world COPD and Asthma Devices industry.
This Insight Report provides a comprehensive analysis of the global COPD and Asthma Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on COPD and Asthma Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global COPD and Asthma Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for COPD and Asthma Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global COPD and Asthma Devices.
The global COPD and Asthma Devices market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
The need for urgency in medication and portability of the drug delivery devices will drive the growth for COPD and Asthma devices.
This report presents a comprehensive overview, market shares, and growth opportunities of COPD and Asthma Devices market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Metered Dose Inhalers (MDI)
Drug Powder Inhalers (DPI)
Soft Mist Inhalers
Jet Nebulizers
Ultrasonic Nebulizers
Others
Segmentation by application
Hospitals
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GlaxoSmithKline Plc
Novartis AG
Merck & Co., Inc
AstraZeneca Plc
Philips Healthcare
3M Health Care
Allied Healthcare Products Inc
Sunovion Pharmaceuticals Inc
GF Healthcare Products
Smith Medicals
Lincare Holdings Inc
Baxter International
Key Questions Addressed in this Report
What is the 10-year outlook for the global COPD and Asthma Devices market?
What factors are driving COPD and Asthma Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do COPD and Asthma Devices market opportunities vary by end market size?
How does COPD and Asthma Devices break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “COPD and Asthma Devices Industry Forecast” looks at past sales and reviews total world COPD and Asthma Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected COPD and Asthma Devices sales for 2023 through 2029. With COPD and Asthma Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world COPD and Asthma Devices industry.
This Insight Report provides a comprehensive analysis of the global COPD and Asthma Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on COPD and Asthma Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global COPD and Asthma Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for COPD and Asthma Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global COPD and Asthma Devices.
The global COPD and Asthma Devices market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
The need for urgency in medication and portability of the drug delivery devices will drive the growth for COPD and Asthma devices.
This report presents a comprehensive overview, market shares, and growth opportunities of COPD and Asthma Devices market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Metered Dose Inhalers (MDI)
Drug Powder Inhalers (DPI)
Soft Mist Inhalers
Jet Nebulizers
Ultrasonic Nebulizers
Others
Segmentation by application
Hospitals
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GlaxoSmithKline Plc
Novartis AG
Merck & Co., Inc
AstraZeneca Plc
Philips Healthcare
3M Health Care
Allied Healthcare Products Inc
Sunovion Pharmaceuticals Inc
GF Healthcare Products
Smith Medicals
Lincare Holdings Inc
Baxter International
Key Questions Addressed in this Report
What is the 10-year outlook for the global COPD and Asthma Devices market?
What factors are driving COPD and Asthma Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do COPD and Asthma Devices market opportunities vary by end market size?
How does COPD and Asthma Devices break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global COPD and Asthma Devices Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for COPD and Asthma Devices by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for COPD and Asthma Devices by Country/Region, 2018, 2022 & 2029
2.2 COPD and Asthma Devices Segment by Type
2.2.1 Metered Dose Inhalers (MDI)
2.2.2 Drug Powder Inhalers (DPI)
2.2.3 Soft Mist Inhalers
2.2.4 Jet Nebulizers
2.2.5 Ultrasonic Nebulizers
2.2.6 Others
2.3 COPD and Asthma Devices Sales by Type
2.3.1 Global COPD and Asthma Devices Sales Market Share by Type (2018-2023)
2.3.2 Global COPD and Asthma Devices Revenue and Market Share by Type (2018-2023)
2.3.3 Global COPD and Asthma Devices Sale Price by Type (2018-2023)
2.4 COPD and Asthma Devices Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 COPD and Asthma Devices Sales by Application
2.5.1 Global COPD and Asthma Devices Sale Market Share by Application (2018-2023)
2.5.2 Global COPD and Asthma Devices Revenue and Market Share by Application (2018-2023)
2.5.3 Global COPD and Asthma Devices Sale Price by Application (2018-2023)
3 Global COPD and Asthma Devices by Company
3.1 Global COPD and Asthma Devices Breakdown Data by Company
3.1.1 Global COPD and Asthma Devices Annual Sales by Company (2018-2023)
3.1.2 Global COPD and Asthma Devices Sales Market Share by Company (2018-2023)
3.2 Global COPD and Asthma Devices Annual Revenue by Company (2018-2023)
3.2.1 Global COPD and Asthma Devices Revenue by Company (2018-2023)
3.2.2 Global COPD and Asthma Devices Revenue Market Share by Company (2018-2023)
3.3 Global COPD and Asthma Devices Sale Price by Company
3.4 Key Manufacturers COPD and Asthma Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers COPD and Asthma Devices Product Location Distribution
3.4.2 Players COPD and Asthma Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for COPD and Asthma Devices by Geographic Region
4.1 World Historic COPD and Asthma Devices Market Size by Geographic Region (2018-2023)
4.1.1 Global COPD and Asthma Devices Annual Sales by Geographic Region (2018-2023)
4.1.2 Global COPD and Asthma Devices Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic COPD and Asthma Devices Market Size by Country/Region (2018-2023)
4.2.1 Global COPD and Asthma Devices Annual Sales by Country/Region (2018-2023)
4.2.2 Global COPD and Asthma Devices Annual Revenue by Country/Region (2018-2023)
4.3 Americas COPD and Asthma Devices Sales Growth
4.4 APAC COPD and Asthma Devices Sales Growth
4.5 Europe COPD and Asthma Devices Sales Growth
4.6 Middle East & Africa COPD and Asthma Devices Sales Growth
5 Americas
5.1 Americas COPD and Asthma Devices Sales by Country
5.1.1 Americas COPD and Asthma Devices Sales by Country (2018-2023)
5.1.2 Americas COPD and Asthma Devices Revenue by Country (2018-2023)
5.2 Americas COPD and Asthma Devices Sales by Type
5.3 Americas COPD and Asthma Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC COPD and Asthma Devices Sales by Region
6.1.1 APAC COPD and Asthma Devices Sales by Region (2018-2023)
6.1.2 APAC COPD and Asthma Devices Revenue by Region (2018-2023)
6.2 APAC COPD and Asthma Devices Sales by Type
6.3 APAC COPD and Asthma Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe COPD and Asthma Devices by Country
7.1.1 Europe COPD and Asthma Devices Sales by Country (2018-2023)
7.1.2 Europe COPD and Asthma Devices Revenue by Country (2018-2023)
7.2 Europe COPD and Asthma Devices Sales by Type
7.3 Europe COPD and Asthma Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa COPD and Asthma Devices by Country
8.1.1 Middle East & Africa COPD and Asthma Devices Sales by Country (2018-2023)
8.1.2 Middle East & Africa COPD and Asthma Devices Revenue by Country (2018-2023)
8.2 Middle East & Africa COPD and Asthma Devices Sales by Type
8.3 Middle East & Africa COPD and Asthma Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of COPD and Asthma Devices
10.3 Manufacturing Process Analysis of COPD and Asthma Devices
10.4 Industry Chain Structure of COPD and Asthma Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 COPD and Asthma Devices Distributors
11.3 COPD and Asthma Devices Customer
12 World Forecast Review for COPD and Asthma Devices by Geographic Region
12.1 Global COPD and Asthma Devices Market Size Forecast by Region
12.1.1 Global COPD and Asthma Devices Forecast by Region (2024-2029)
12.1.2 Global COPD and Asthma Devices Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global COPD and Asthma Devices Forecast by Type
12.7 Global COPD and Asthma Devices Forecast by Application
13 Key Players Analysis
13.1 GlaxoSmithKline Plc
13.1.1 GlaxoSmithKline Plc Company Information
13.1.2 GlaxoSmithKline Plc COPD and Asthma Devices Product Portfolios and Specifications
13.1.3 GlaxoSmithKline Plc COPD and Asthma Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GlaxoSmithKline Plc Main Business Overview
13.1.5 GlaxoSmithKline Plc Latest Developments
13.2 Novartis AG
13.2.1 Novartis AG Company Information
13.2.2 Novartis AG COPD and Asthma Devices Product Portfolios and Specifications
13.2.3 Novartis AG COPD and Asthma Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Novartis AG Main Business Overview
13.2.5 Novartis AG Latest Developments
13.3 Merck & Co., Inc
13.3.1 Merck & Co., Inc Company Information
13.3.2 Merck & Co., Inc COPD and Asthma Devices Product Portfolios and Specifications
13.3.3 Merck & Co., Inc COPD and Asthma Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Merck & Co., Inc Main Business Overview
13.3.5 Merck & Co., Inc Latest Developments
13.4 AstraZeneca Plc
13.4.1 AstraZeneca Plc Company Information
13.4.2 AstraZeneca Plc COPD and Asthma Devices Product Portfolios and Specifications
13.4.3 AstraZeneca Plc COPD and Asthma Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 AstraZeneca Plc Main Business Overview
13.4.5 AstraZeneca Plc Latest Developments
13.5 Philips Healthcare
13.5.1 Philips Healthcare Company Information
13.5.2 Philips Healthcare COPD and Asthma Devices Product Portfolios and Specifications
13.5.3 Philips Healthcare COPD and Asthma Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Philips Healthcare Main Business Overview
13.5.5 Philips Healthcare Latest Developments
13.6 3M Health Care
13.6.1 3M Health Care Company Information
13.6.2 3M Health Care COPD and Asthma Devices Product Portfolios and Specifications
13.6.3 3M Health Care COPD and Asthma Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 3M Health Care Main Business Overview
13.6.5 3M Health Care Latest Developments
13.7 Allied Healthcare Products Inc
13.7.1 Allied Healthcare Products Inc Company Information
13.7.2 Allied Healthcare Products Inc COPD and Asthma Devices Product Portfolios and Specifications
13.7.3 Allied Healthcare Products Inc COPD and Asthma Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Allied Healthcare Products Inc Main Business Overview
13.7.5 Allied Healthcare Products Inc Latest Developments
13.8 Sunovion Pharmaceuticals Inc
13.8.1 Sunovion Pharmaceuticals Inc Company Information
13.8.2 Sunovion Pharmaceuticals Inc COPD and Asthma Devices Product Portfolios and Specifications
13.8.3 Sunovion Pharmaceuticals Inc COPD and Asthma Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sunovion Pharmaceuticals Inc Main Business Overview
13.8.5 Sunovion Pharmaceuticals Inc Latest Developments
13.9 GF Healthcare Products
13.9.1 GF Healthcare Products Company Information
13.9.2 GF Healthcare Products COPD and Asthma Devices Product Portfolios and Specifications
13.9.3 GF Healthcare Products COPD and Asthma Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 GF Healthcare Products Main Business Overview
13.9.5 GF Healthcare Products Latest Developments
13.10 Smith Medicals
13.10.1 Smith Medicals Company Information
13.10.2 Smith Medicals COPD and Asthma Devices Product Portfolios and Specifications
13.10.3 Smith Medicals COPD and Asthma Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Smith Medicals Main Business Overview
13.10.5 Smith Medicals Latest Developments
13.11 Lincare Holdings Inc
13.11.1 Lincare Holdings Inc Company Information
13.11.2 Lincare Holdings Inc COPD and Asthma Devices Product Portfolios and Specifications
13.11.3 Lincare Holdings Inc COPD and Asthma Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Lincare Holdings Inc Main Business Overview
13.11.5 Lincare Holdings Inc Latest Developments
13.12 Baxter International
13.12.1 Baxter International Company Information
13.12.2 Baxter International COPD and Asthma Devices Product Portfolios and Specifications
13.12.3 Baxter International COPD and Asthma Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Baxter International Main Business Overview
13.12.5 Baxter International Latest Developments
14 Research Findings and Conclusion